The Pfizer plant in McPherson laid off 80 people, KSN News confirmed on Thursday. Those impacted included ...

WICHITA, Kan. (KWCH) - Dozens of salaried employees at the Pfizer plant in McPherson, Kansas are being laid off. Kansas ...

McPHERSON, Kan. (KAKE) - Pfizer is laying off dozens of salaried employees at its plant in McPherson, Kansas. According to ...

MCPHERSON— Tucky Allen with KansasWorkforceONE confirmed to Hutch Post Thursday morning that there have been layoffs at ...

Pfizer’s transition from pandemic reliance to growth in oncology and rare diseases reflects a strategic pivot, supported by recent acquisitions, despite the challenge of rising debt ...

Pfizer’s stock has dropped in the double digits over three years. The company faces declines in sales of its coronavirus products and the loss of exclusivity of other major products. But over ...

Pfizer stock (NYSE: PFE) is trading at about $30 per share, not far from the lows seen in recent years. Could the stock rise by over 2x in value over the next few years? Does this sound a bit ...

Pfizer's acquisition of Seagen for $43 billion enhances its ADC technology, potentially expanding its oncology franchise and driving future growth. PFE's development of the oral GLP-1 receptor ...

Sept 26 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks ...

Pfizer said Wednesday that it was removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks of severe safety events, including deaths.

Pfizer PFE3.46%increase; green up pointing triangle said it is voluntarily withdrawing all lots of its sickle-cell drug Oxbryta in all markets where it is approved, two years after acquiring its ...

The Pfizer plant in McPherson laid off 80 people, KSN News confirmed on Thursday. Tucky Allen, Kansas WorkforceONE, says ...